Establishing a pediatric solid tumor PDX biobank for precision oncology research

Establishing a pediatric solid tumor PDX biobank for precision oncology research

Developing advanced preclinical models and targeted therapies is essential for reducing cancer-related deaths in children with solid tumors. Patient-derived xenografts (PDX) have the potential to replicate key elements of the original tumor, including morphology, genetic alterations, and microenviro...

Full description

Saved in:
Bibliographic Details
Main Authors: Larissa Akemi Kido, Milena Rodrigues Marusco, Ellen Aparecida da Silva, Laís Do Carmo, Ana Beatriz Teodoro Borges, Felipe Luz Torres Silva, Juliana Silveira Ruas, Dieila Giomo de Lima, Larissa de Abreu Fernandes, Camila Maia Martin Daiggi, Izilda Aparecida Cardinalli, Mayara Ferreira Euzébio, Patricia Yoshioka Jotta, Mariana Maschietto, Priscila Pini Zenatti
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Cancer Biology & Therapy
Subjects:
Patient-derived xenograft
solid tumors
pediatric cancer
precision medicine
Online Access:https://www.tandfonline.com/doi/10.1080/15384047.2025.2541974
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/15384047.2025.2541974

Similar Items